<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1817-5996</journal-id>
<journal-title><![CDATA[Revista Cubana de Reumatología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cuba Reumatol]]></abbrev-journal-title>
<issn>1817-5996</issn>
<publisher>
<publisher-name><![CDATA[Editorial CIMEQ]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1817-59962018000200006</article-id>
<article-id pub-id-type="doi">10.5281/zenodo.1215091</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Dermatomiositis y colitis ulcerosa: una asociación infrecuente]]></article-title>
<article-title xml:lang="en"><![CDATA[Dermatomyositis and ulcerative colitis: an infrecuent association]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pila Pérez]]></surname>
<given-names><![CDATA[Rafael]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Artola González]]></surname>
<given-names><![CDATA[Javier]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pila Peláez]]></surname>
<given-names><![CDATA[Rafael]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[León Acosta]]></surname>
<given-names><![CDATA[Pedro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rosales Torres]]></surname>
<given-names><![CDATA[Pedro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Ciencias Médicas de Camagüey Hospital Provincial Docente Manuel Ascunce Domenech ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2018</year>
</pub-date>
<volume>20</volume>
<numero>2</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1817-59962018000200006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1817-59962018000200006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1817-59962018000200006&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  La incidencia de la miopatía inflamatoria idiopática es de 4 a 15 casos por millón de habitantes y su prevalencia de 60 casos por cada millón de habitantes. Dada la identificación de formas clínicas es posible que estas cifras de incidencia y prevalencia aumenten en los próximos años. La colitis ulcerosa ha ido en aumento afectando al 2 % de la población mundial. Los síntomas están determinados por la extensión y gravedad de las lesiones, teniendo un curso crónico que puede evolucionar por brotes y no existe tratamiento médico curativo. La asociación de la dermatomiositis y la colitis ulcerativa es extremadamente infrecuente.  Objetivo:  Presentar un caso diagnosticado con la asociación de dermatomiositis y colitis ulcerosa.  Caso Clínico:  Paciente de 70 años, femenina, blanca, ama de casa, sin antecedentes familiares de interés ni epidemiológicos. Refiere que a los cincuenta años presentó cuadros diarreicos acompañados de dolor abdominal, moco y pus. Hace un año aproximadamente viene presentando debilidad muscular a nivel de los hombros, lo que dificultaba levantar los brazos. Se realizaron exámenes de laboratorio, imagenológicos e histopatológicos que mostraron la presencia de una Dermatomiositis asociada a colitis ulcerativa. Señalamos las características clínicas, medios diagnósticos y la terapéutica empleada en nuestra enferma.  Conclusiones:  Se presentó el caso de una paciente con manifestaciones clínicas de dermatomiositis y colitis ulcerativa. Esta asociación es muy infrecuente y debe ser tenida en cuenta por los médicos que consultan a estos enfermos; debido a que ambas tienen una base inmunológica y pueden expresarse de variadas formas.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  The incidence of idiopathic inflammatory myopathy is from 4 to 15 cases per million inhabitants and its prevalence of 60 cases per million inhabitants. Given the identification of clinical forms it is possible that these figures of incidence and prevalence increase in the coming years. Ulcerative colitis has been increasing, affecting 2% of the world population. The symptoms are determined by the extent and severity of the lesions, having a chronic course that can evolve outbreaks and there is no curative medical treatment. The association of dermatomyositis and ulcerative colitis is extremely infrequent.  Objective:  To present a case diagnosed with the association of dermatomyositis and ulcerative colitis.  Clinical Case:  Patient of 70 years, female, white, housewife, with no family history of interest or epidemiological. He reports that at age fifty he presented with diarrhea accompanied by abdominal pain, mucus and pus. About a year ago, muscle weakness appeared at the level of the shoulders, which made it difficult to raise the arms. Laboratory, imaging and histopathological examinations were performed, which showed the presence of a dermatomyositis associated with ulcerative colitis. We point out the clinical characteristics, diagnostic means and the therapy used in our patient.  Conclusions:  The case of a patient with clinical manifestations of dermatomyositis and ulcerative colitis was presented. This association is very infrequent and should be taken into account by the doctors who consult these patients; because both have an immunological basis and can be expressed in various ways.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[miopatía]]></kwd>
<kwd lng="es"><![CDATA[dermatomiositis]]></kwd>
<kwd lng="es"><![CDATA[colitis]]></kwd>
<kwd lng="en"><![CDATA[myopathy]]></kwd>
<kwd lng="en"><![CDATA[dermatomyositis colitis]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hachulla]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dermatomyositis and Polymyositis clinicalaspects and treatment]]></article-title>
<source><![CDATA[Ann Med Intenne]]></source>
<year>2001</year>
<volume>152</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>455-647</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bohan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Peter]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Polymyositis and Dermatomyositis]]></article-title>
<source><![CDATA[New Eng J Med]]></source>
<year>1975</year>
<volume>292</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>344-403</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grau]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Uryent]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<collab>Casa de MontPou F.Candella Ch.Lopez F.Urbano Marquez A</collab>
<source><![CDATA[Enfermedades musculares: En Farreras R. Dermatomiositis]]></source>
<year>2002</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Ed Hancourt]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miller]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<source><![CDATA[Polimiositis y Dermatomiositis.En: Principios de Medicina Interna, Cecil- Goldman, Edición 24,]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Ed Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Manmhen]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dermatomyositis and Polymyositis Clinical presentation autoantibodies and pathogenesis]]></article-title>
<source><![CDATA[Ann Ny Acad SC]]></source>
<year>2010</year>
<page-range>1124-347</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zahr]]></surname>
<given-names><![CDATA[ZA]]></given-names>
</name>
<name>
<surname><![CDATA[Baer]]></surname>
<given-names><![CDATA[AN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Malignancy in myositis]]></article-title>
<source><![CDATA[Curr Rheumathol Rep]]></source>
<year>2011</year>
<volume>13</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>208-15</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rossi]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Paz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Valdés]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Valencia]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mona]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Polimiositis y compromiso cardíaco]]></article-title>
<source><![CDATA[Acta Med Colom]]></source>
<year>2014</year>
<volume>39</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>293-7</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Celebis]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Gue]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kamali]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Inanc]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ocal]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Amyopathie Dermatomyositis associated with cervical cancer]]></article-title>
<source><![CDATA[Clinical Rheumatol]]></source>
<year>2002</year>
<volume>20</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>438-40</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miller]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Vleugels]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Clinical manifestations of Dermatomyositis and Polymyositis in adult]]></source>
<year>2013</year>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hano García]]></surname>
<given-names><![CDATA[OM]]></given-names>
</name>
<name>
<surname><![CDATA[Andrade Gomes]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Villa Jiménez]]></surname>
<given-names><![CDATA[OM]]></given-names>
</name>
<name>
<surname><![CDATA[González Fabian]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Wood Rodríguez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización de pacientes con colitis ulcerosa atendidos en centro de nivel terciario]]></article-title>
<source><![CDATA[Rev cubana med]]></source>
<year>2016</year>
<volume>55</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Panes]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Enfermedad inflamatoria intestinal.En: Farreras R. Colitis Ulcerosa, Medicina Interna. 14 ed]]></source>
<year>2000</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Ed Harcourt]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sean]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ulcerative colitis A patient of Journey]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2012</year>
<volume>344</volume>
<page-range>2947</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mendeloff]]></surname>
<given-names><![CDATA[AI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Algunas características epidemiológicas de la colitis ulcerativa y enteritis regional]]></article-title>
<source><![CDATA[Gastroenterology]]></source>
<year>1966</year>
<volume>51</volume>
<page-range>742</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Blumberg]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
</person-group>
<source><![CDATA[Inflamatory bowel disease: Medical Considerations. In Greenberger NJ, Burakoff F. Conment diagnosis Treatment. Gastroenterology, hepatology, Endoscopy]]></source>
<year>2009</year>
<publisher-loc><![CDATA[Boston ]]></publisher-loc>
<publisher-name><![CDATA[Ed. Mc Graw-Hill]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hengs Man]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Vanden Hoogen]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Van Engelew]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Treatment of the inflammatory myopathies update and practical recommendations]]></article-title>
<source><![CDATA[Exp Opin Pharmaco Therapy]]></source>
<year>2010</year>
<volume>10</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1083-90</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
